28 July 2010, 5:51 am
TUSTIN, CA--(Marketwire - July 28, 2010) - Radient Pharmaceuticals Corporation (RPC) ( NYSE Amex : RPC ) announced today its China-based subsidiary Jade Pharmaceuticals Inc. (JPI) signed a letter of intent (LOI) under which JPI will acquire Shanxi BaoTai Pharmaceutical Co., Ltd. (BaoTai), a privately owned pharmaceutical manufacturing company located in Taiyuan China, through a non-taxable ...... Read More »